Table 4.
Thrombotic Event | N (%) |
---|---|
Any Events Before Enrollmenta | 468 (18.8) |
Before diagnosisb | 296 (11.9) |
Venous | 166 (6.7) |
Arterial | 142 (5.7) |
Between diagnosis and enrollmentb | 207 (8.3) |
Venous | 130 (5.2) |
Arterial | 87 (3.5) |
More than one thrombotic event | 115 (4.6) |
Venous Events Before Enrollment | 279 (11.2) |
Deep-vein thrombosis | 151 (6.1) |
Pulmonary embolism | 64 (2.6) |
Superficial venous thrombosis | 30 (1.2) |
Portal vein thrombosis | 20 (0.8) |
Cerebral vein/sinus thrombosis | 17 (0.7) |
Splenic vein thrombosis | 9 (0.4) |
Retinal vein thrombosis | 7 (0.3) |
Visceral/splanchnic vein thrombosis | 1 (<0.1) |
Other | 42 (1.7) |
Arterial Events Before Enrollment | 218 (8.8) |
Cerebrovascular arterial thrombosis | 126 (5.1) |
Acute myocardial infarction | 44 (1.8) |
Peripheral arterial thrombosis | 14 (0.6) |
Splenic infarction | 6 (0.2) |
Retinal artery thrombosis | 4 (0.2) |
Visceral arterial thrombosis | 1 (<0.1) |
Other | 38 (1.5) |
Patients without known PV diagnosis date were excluded from evaluable patient population.
Thrombotic events without event dates were excluded.
Patient groups reporting events “before diagnosis” and “between diagnosis and enrollment” are not mutually exclusive.